Opioid consumption in total intravenous anesthesia is reduced with dexmedetomidine: a comparative study with remifentanil in gynecologic videolaparoscopic surgery

Journal of Clinical Anesthesia

Volumn 19, Issue 4, 2007, Pages 280-285

  Bulow, Neusa Maria H ^a   Barbosa, Nilda Vargas ^b   Rocha, Joao Batista Teixeira ^b  

^a Hospital Universitario de Santa Maria   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Cortisol; Dexmedetomidine; Glucose; Remifentanil; TIVA; Videolaparoscopy; 2 agonist

Indexed keywords

CISATRACURIUM; DEXMEDETOMIDINE; DIPYRONE; FENTANYL; GLUCOSE; HYDROCORTISONE; KETOPROFEN; OPIATE; OXYGEN; PROPOFOL; REMIFENTANIL;

ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DIASTOLIC BLOOD PRESSURE; DREAMING; ENDOTRACHEAL INTUBATION; EXTUBATION; FEMALE; GYNECOLOGIC SURGERY; HEALTH STATUS; HEART RATE; HOSPITAL DISCHARGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERALGESIA; HYPERGLYCEMIA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INTRAOPERATIVE PERIOD; INTRAVENOUS ANESTHESIA; LAPAROSCOPIC SURGERY; LEG MOVEMENT; MEAN ARTERIAL PRESSURE; MINIMALLY INVASIVE SURGERY; MUSCLE RIGIDITY; PATIENT CONTROLLED ANALGESIA; POSTANESTHESIA CARE; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SIDE EFFECT; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SURGICAL PATIENT; SYSTOLIC BLOOD PRESSURE; UNIVERSITY HOSPITAL;

EID: 84984559482     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2007.01.004     Document Type: Article

References (48)

1. Aho M., Erkola O., Kallio A., Scheinin H., and Korttila K. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth Analg 75 (1992) 940-946
2. Ebert T., and Maze M. Dexmedetomidine: another arrow for the clinician's quiver. Anesthesiology 101 (2004) 568-570
3. Ebert T.J., Hall J.E., Barney J.A., Uhrich T.D., and Colinco M.D. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93 (2000) 382-394
4. Hall J.E., Uhrich T.D., Barney J.A., Arain S.R., and Ebert T.J. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 90 (2000) 699-705
5. Hayashi Y., and Maze M. Alpha (2) adrenoceptor agonists and anesthesia. Br J Anaesth 71 (1993) 108-118
6. Kamibayashi T., and Maze M. Clinical uses of alpha (2)-adrenergic agonists. Anesthesiology 93 (2000) 1345-1349
7. Kamibayashi T., Harasawa K., and Maze M. Alpha-2 adrenergic agonists. Can J Anaesth 44 (1997) R13-R18
8. Talke P. Receptor-specific reversible sedation-beginning of new era of anesthesia?. Anesthesiology 89 (1998) 560-561
9. Venn R.M., and Grounds R.M. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 87 (2001) 684-690
10. Aantaa R., Jaakola M.L., Kallio A., and Kanto J. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology 86 (1997) 1055-1060
11. Aho M., Lehtinen A.M., Erkola O., Kallio A., and Korttila K. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology 74 (1991) 997-1002
12. Fragen R.J., and Fitzgerald P.C. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years. J Clin Anesth 11 (1999) 466-470
13. Khan Z.P., Munday I.T., Jones R.M., Thornton C., Mant T.G., and Amin D. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers: 1. Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 83 (1999) 372-380
14. Jaakola M.L., Ali-Melkkila T., Kanto J., Kallio A., Scheinin H., and Scheinin M. Dexmedetomidine reduces intraocular pressure, intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgery. Br J Anaesth 68 (1992) 570-575
15. Ramsay M.A., and Luterman D.L. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 101 (2004) 787-790
16. Aho M., Scheinin M., Lehtinen A.M., Erkola O., Vuorinen J., and Korttila K. Intramuscularly administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. Anesth Analg 75 (1992) 932-939
17. Bloor B.C., Ward D.S., Belleville J.P., and Maze M. Effects of intravenous dexmedetomidine in humans. 2. Hemodynamic changes. Anesthesiology 77 (1992) 1134-1142
18. Hogue C.W.J., Talke P., Stein P.K., Richardson C., Domitrovich P.P., and Sessler D.I. Autonomic nervous system responses during sedative infusions of dexmedetomidine. Anesthesiology 97 (2002) 592-598
19. 2 adrenoceptors in pain modulation: which subtype should be targeted to produce analgesia?. Anesthesiology 92 (2000) 934
20. Sumping S.T., El-Moalem H.E., Hsu Y.W., Young C., and Somma J. Comparison of analgesic effects: dexmedetomidine against remifentanil [Abstract]. Anesthesiology 95 (2001) A458
21. Talke P., Richardson C.A., Scheinin M., and Fisher D.M. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 85 (1997) 1136-1142
22. Talke P., Tayefeh F., Sessler D.I., et al. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology 87 (1997) 835-841
23. Nelson L.E., Lu J., Guo T.Z., Saper C.B., Franks N.P., and Maze M. The alpha (2)-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 98 (2003) 428-436
24. Venn R.M., Hell J., and Grounds R.M. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 4 (2000) 302-308
25. Grant S.A., Breslin D.S., MacLeod D.B., Gleason D., and Martin G. Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases. J Clin Anesth 16 (2004) 124-126
26. Glass P.S.A., Gan T.J., and Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 89 (1999) S7-S14
27. Guignard B., Bossard A.E., Coste C., et al. Intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93 (2000) 409-417
28. Gustorff B., Kozek-Langenecker S., and Kress G.H. Gabapentin: the first preemptive anti-hyperalgesic for opioid withdrawal hyperalgesia?. Anesthesiology 98 (2003) 1520-1521
29. Hood D.D., Curry R., and Eisenach J.C. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 97 (2003) 810-815
30. Koppert W., Sittl R., Scheuber K., Alsheimer M., Schmelz M., and Schuttler J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by s-ketamine and clonidine in humans. Anesthesiology 99 (2003) 152-159
31. Sinz E.H., Kofke A.W., and Garman R.H. Phenytoin, midazolam, and naloxone protect against fentanyl-induced brain damage in rats. Anesth Analg 91 (2000) 1443-1449
32. Kofke A.W., Attallah A.F., Kuwabara H., et al. The neuropathologic effects in rats and neurometabolic effects in humans of large-dose remifentanil. Anesth Analg 94 (2002) 1229-1236
33. Maze M., Virtanen R., Daunt D., Banks S.J.M., Stover E.P., and Feldman D. Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis-in vivo and in vitro studies. Anesth Analg 73 (1991) 204-208
34. Ambrisko T.D., and Hikasa Y. The antagonistic effects of atipamezole and yohimbine on stress-related neurohormonal and metabolic responses induced by medetomidine in dogs. Can J Vet Res 67 (2003) 64-67
35. Angel I., Bidet S., and Langer S.Z. Pharmacological characterization of the hyperglycemia induced by alpha-2 adrenoceptor agonists. J Pharmacol Exp Ther 246 (1988) 1098-1103
36. Cronin A.J., Bonafide C.P., DiVittore N.A., Gordon V., and Aucutt-Walters N.M. Remifentanil infusion in normal volunteers blunts the morning rise in cortisol but does not disturb the circadian rhythm of melatonin [Abstract]. Anesthesiology 96 (2002) A313
37. 2 adrenergic blockade diminishes the potentiating effect increased cholinergic tone on such stimulation in normal men. J Clin Endocrinol Metab 73 (1991) 251-256
38. Fontaine J., Gilbert S., Pypendop B., and Verstegen J. Use of dexmedetomidine as stimulating agent in the GH-test in the dog and interest of the induced hyperglycemic response in dermatology. Ann Med Vet 140 (1996) 65-70
39. Ledowski T., Fudickar W., Tonner P.H., Bein B., and Scholz J. Intraoperative stress response: anesthesia with sevoflurane/remifentanil vs. propofol/remifentanil [Abstract]. Anesthesiology A74 (2002)
40. Myre K., Raeder J., Rostrup M., Buanes T., and Stokland O. Catecholamine release during laparoscopic fundoplication with high and low doses of remifentanil. Acta Anaesthesiol Scand 47 (2003) 267-273
41. Venn R.M., Bryant G., Hall M., and Grounds R.M. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 86 (2001) 650-656
42. Hamasaki J., Tsuneyoshi I., Katai R., Hidaka T., Boyle W.A., and Kanmura Y. Dual 2-adrenergic agonist and 1-adrenergic antagonist actions of dexmedetomidine on human isolated endothelium-denuded gastroepiploic arteries. Anesth Analg 94 (2002) 1434-1440
43. Talke P., Lobo E., and Brown R. Systemically administered alpha (2)-agonist-induced peripheral vasoconstriction in human. Anesthesiology 99 (2003) 65-70
44. Feld J.M., Hoffman W.E., Stechert M.M., Hoffman I.W., and Ananda R.C. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth 18 (2006) 24-28
45. Videira R.L., and Fereira R.M. Dexmedetomidine and asystole. Anesthesiology 101 (2004) 1479
46. Manecke G.R.J., Ingersoll-Weng E., and Thistlethwaite P.A. Dexmedetomidine and asystole. Anesthesiology 101 (2004) 1479-1480
47. Dershwitz M., Michalowski P., Chang Y.C., Rosow C.E., and Conlay L.A. Postoperative nausea and vomiting after total intravenous anesthesia with propofol and remifentanil or alfentanil: how important is the opioid?. J Clin Anesth 14 (2002) 275-278
48. Kushikata T., Hirota K., Yoshida H., Kubota T., Ishihara H., and Matsuki A. Alpha-2 adrenoceptor activity affects propofol-induced sleep time. Anesth Analg 94 (2002) 1201-1206